We are live on ! Find out more
AEMD icon

Aethlon Medical

11 hedge funds and large institutions have $975K invested in Aethlon Medical in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital invested

Capital invested by funds: $684K → $975K (+$292K)

0% more funds holding

Funds holding: 1111 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q4 2017 in Review

11 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2017, worth a combined $975K — up 43% from $684K a quarter earlier.

Fund positioning in AEMD was balanced in Q4 2017: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $231K. The largest seller was Virtu Financial, exiting entirely with an estimated $57K sold.

  • 11 institutional investors held Aethlon Medical (AEMD) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $975K of Aethlon Medical stock for Q4 2017, up 43% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q4 2017 and 3 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q4 2017 was Vanguard Group, an estimated $231K added.
  • The largest Aethlon Medical seller in Q4 2017 was Virtu Financial, an estimated $57K sold.

Based on aggregated 13F filings for Q4 2017.